Article info
PDFEconomics
Warfarin was cost-effective for stroke prophylaxis in nonvalvular atrial fibrillation with additional risk factors
Citation
Warfarin was cost-effective for stroke prophylaxis in nonvalvular atrial fibrillation with additional risk factors
Online issue publication
February 27, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions